These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 20156940)

  • 1. Characteristics, outcomes, and predictors of mortality at 3 months and 1 year in patients hospitalized for acute heart failure.
    Harjola VP; Follath F; Nieminen MS; Brutsaert D; Dickstein K; Drexler H; Hochadel M; Komajda M; Lopez-Sendon JL; Ponikowski P; Tavazzi L
    Eur J Heart Fail; 2010 Mar; 12(3):239-48. PubMed ID: 20156940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population.
    Nieminen MS; Brutsaert D; Dickstein K; Drexler H; Follath F; Harjola VP; Hochadel M; Komajda M; Lassus J; Lopez-Sendon JL; Ponikowski P; Tavazzi L; ;
    Eur Heart J; 2006 Nov; 27(22):2725-36. PubMed ID: 17000631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure: an observational study of treatment rates and clinical outcome.
    Gotsman I; Rubonivich S; Azaz-Livshits T
    Isr Med Assoc J; 2008 Mar; 10(3):214-8. PubMed ID: 18494235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics, outcomes, and predictors of 1-year mortality in patients hospitalized for acute heart failure.
    Siirilä-Waris K; Lassus J; Melin J; Peuhkurinen K; Nieminen MS; Harjola VP;
    Eur Heart J; 2006 Dec; 27(24):3011-7. PubMed ID: 17127708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure and chronic kidney disease.
    Berger AK; Duval S; Manske C; Vazquez G; Barber C; Miller L; Luepker RV
    Am Heart J; 2007 Jun; 153(6):1064-73. PubMed ID: 17540211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central venous pressure at emergency room presentation predicts cardiac rehospitalization in patients with decompensated heart failure.
    Uthoff H; Thalhammer C; Potocki M; Reichlin T; Noveanu M; Aschwanden M; Staub D; Arenja N; Socrates T; Twerenbold R; Mutschmann-Sanchez S; Heinisch C; Jaeger KA; Mebazaa A; Mueller C
    Eur J Heart Fail; 2010 May; 12(5):469-76. PubMed ID: 20223880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The rationale and indications for angiotensin receptor blockers in heart failure.
    Bybee KA; Das S; O'Keefe JH
    Heart Fail Clin; 2006 Jan; 2(1):81-8. PubMed ID: 17386879
    [No Abstract]   [Full Text] [Related]  

  • 9. Contemporary management of octogenarians hospitalized for heart failure in Europe: Euro Heart Failure Survey II.
    Komajda M; Hanon O; Hochadel M; Lopez-Sendon JL; Follath F; Ponikowski P; Harjola VP; Drexler H; Dickstein K; Tavazzi L; Nieminen M
    Eur Heart J; 2009 Feb; 30(4):478-86. PubMed ID: 19106198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discharge use of angiotensin receptor blockers provides comparable effects with angiotensin-converting enzyme inhibitors on outcomes in patients hospitalized for heart failure.
    Tsuchihashi-Makaya M; Furumoto T; Kinugawa S; Hamaguchi S; Goto K; Goto D; Yamada S; Yokoshiki H; Takeshita A; Tsutsui H;
    Hypertens Res; 2010 Mar; 33(3):197-202. PubMed ID: 19960016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of mortality after discharge in patients hospitalized with heart failure: an analysis from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).
    O'Connor CM; Abraham WT; Albert NM; Clare R; Gattis Stough W; Gheorghiade M; Greenberg BH; Yancy CW; Young JB; Fonarow GC
    Am Heart J; 2008 Oct; 156(4):662-73. PubMed ID: 18926148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short to long term mortality of patients hospitalised with heart failure in the Czech Republic--a report from the EuroHeart Failure Survey.
    Rosolova H; Cech J; Simon J; Spinar J; Jandova R; Widimský sen J; Holubec L; Topolcan O
    Eur J Heart Fail; 2005 Aug; 7(5):780-3. PubMed ID: 16051521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of long-term (4-year) mortality in elderly and young patients with acute heart failure.
    Barsheshet A; Shotan A; Cohen E; Garty M; Goldenberg I; Sandach A; Behar S; Zimlichman E; Lewis BS; Gottlieb S;
    Eur J Heart Fail; 2010 Aug; 12(8):833-40. PubMed ID: 20494926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A three year clinical review of the impact of angiotensin converting enzyme inhibitors on the intra hospital mortality of congestive heart failure in Nigerians.
    Adewole AD; Ikem RT; Adigun AQ; Akintomide AO; Balogun MO; Ajayi AA
    Cent Afr J Med; 1996 Aug; 42(8):253-5. PubMed ID: 8990572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Heart failure: critical patients].
    Fabbri G; Gorini M; Maggioni AP; Oliva F;
    G Ital Cardiol (Rome); 2007 Sep; 8(9):568-73. PubMed ID: 17972426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Short-term prognosis and treatment of patients hospitalized for acute heart failure in a regional hospital without a cardiocentre].
    Zeman K; Pohludková L; Spinar J; Jarkovský J; Littnerová S; Dušek L; Miklík R; Felšöci M; Pařenica J
    Vnitr Lek; 2012 Apr; 58(4):273-9. PubMed ID: 22559800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex differences in the effectiveness of angiotensin receptor blockers and angiotensin converting enzyme inhibitors in patients with congestive heart failure--a population study.
    Hudson M; Rahme E; Behlouli H; Sheppard R; Pilote L
    Eur J Heart Fail; 2007; 9(6-7):602-9. PubMed ID: 17383932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of valsartan for the treatment of heart-failure patients not receiving ACE inhibitors: a budget impact analysis.
    Smith DG; Cerulli A; Frech FH
    Clin Ther; 2005 Jun; 27(6):951-9. PubMed ID: 16117995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database.
    Yancy CW; Lopatin M; Stevenson LW; De Marco T; Fonarow GC;
    J Am Coll Cardiol; 2006 Jan; 47(1):76-84. PubMed ID: 16386668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New-onset atrial fibrillation is an independent predictor of in-hospital mortality in hospitalized heart failure patients: results of the EuroHeart Failure Survey.
    Rivero-Ayerza M; Scholte Op Reimer W; Lenzen M; Theuns DA; Jordaens L; Komajda M; Follath F; Swedberg K; Cleland JG
    Eur Heart J; 2008 Jul; 29(13):1618-24. PubMed ID: 18515809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.